A chiral resolving agent separates dihydropyrazole intermediates by precipitation, avoiding costly chromatography while supporting scalable enantiomer enrichment.
A chiral resolving agent enables co-crystallization and solid-liquid separation of the (R)-triazole enantiomer with lower cost than column resolution.
A cyclohexanediamine resolving agent separates brivaracetam intermediates by crystallization, improving chiral purity, yield, and process cost.